Search Articles

View query in Help articles search

Search Results (1 to 10 of 1728 Results)

Download search results: CSV END BibTex RIS


Feasibility and Effectiveness of Using Wearable Activity Trackers in Youth: A Systematic Review

Feasibility and Effectiveness of Using Wearable Activity Trackers in Youth: A Systematic Review

Wearable devices used in the included studies: (a) Fitbit One, (b) the PAM (new model shown), (c) Sense Wear, (d) Actical, (e) Polar Active, and (f) Polar heart rate monitor. In the Netherlands, Slootmaker and colleagues [26] investigated the effectiveness of the PAM monitor in combination with PAM COACH for increasing the physical activity levels of adolescents (aged 13-17 years; n=87).

Nicola D D Ridgers, Melitta A McNarry, Kelly A Mackintosh

JMIR Mhealth Uhealth 2016;4(4):e129

Parental Perspectives of a Wearable Activity Tracker for Children Younger Than 13 Years: Acceptability and Usability Study

Parental Perspectives of a Wearable Activity Tracker for Children Younger Than 13 Years: Acceptability and Usability Study

This is contrary to Ridgers et al [21], where despite emphasizing a desire to access sleep data, adolescents felt difficulties and discomfort associated with wearing the activity tracker prevented this. Promoting good sleep habits is becoming increasingly important given the introduction of 24-hour movement guidelines in some countries [45], though there are concerns regarding the accuracy of wearables for tracking sleep [46].

Kelly A D Mackintosh, Stephanie E Chappel, Jo Salmon, Anna Timperio, Kylie Ball, Helen Brown, Susie Macfarlane, Nicola D Ridgers

JMIR Mhealth Uhealth 2019;7(11):e13858

Ayurvedic Management of Presbycusis (Project TOPMAC): Protocol for an Exploratory Randomized Controlled Trial

Ayurvedic Management of Presbycusis (Project TOPMAC): Protocol for an Exploratory Randomized Controlled Trial

The administration of the water extract from Ashwagandha (100 mg/kg/d) with drinking water for 8 months has shown to be safe and showed no toxicity in rats [21]. Ashwagandha may operate as a gamma-aminobutyric acid mimetic, cholinomimetic, and agonist for α-7 nicotinic receptors for cognitive function protection [22]. However, no clinical trials or documented data are available on the efficacy of these drugs for presbycusis treatment, despite being widely used in clinics.

Krishna Kumar V, Sanjeev V Thomas, Murugan C Nair, Parvathy G Nair, Nisha M L, Anuradha S, Arunabh Tripathi, Pallavi Mundada, Babita Yadav, B C S Rao, Sudhakar D, Srikanth N

JMIR Res Protoc 2024;13:e55089

Cookie Consent

We use our own cookies and third-party cookies so that we can show you this website and better understand how you use it, with a view to improving the services we offer. If you continue browsing, we consider that you have accepted the cookies.